NASDAQ:RPTX
Repare Therapeutics Inc. Stock News
$3.69
-0.0100 (-0.270%)
At Close: May 14, 2024
2 Biotech Stocks ARK Invest Bought in June
06:25am, Monday, 07'th Jun 2021
Should you follow Cathie Wood's latest genomic revolution investments?
Repare Therapeutics to Participate at the 42nd Annual Goldman Sachs Virtual Global Healthcare Conference
07:00am, Wednesday, 02'nd Jun 2021
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq:RPTX), a leading clinical-stage precision oncology company enabled by its proprietary
Repare Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
04:45pm, Thursday, 13'th May 2021
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietar
Repare Therapeutics to Present at the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference
07:00am, Tuesday, 13'th Apr 2021
CAMBRIDGE, Mass. & MONTREAL, Quebec--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its pr
Repare Therapeutics to Highlight Program Progress for RP-6306 at Today's Virtual Investor Day Event
11:05am, Thursday, 08'th Apr 2021
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietar
Repare Therapeutics Insiders Establish Automatic Securities Disposition Plans
04:09pm, Thursday, 31'st Dec 2020
CAMBRIDGE, Mass. & MONTREAL, Quebec--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its pr
Repare Therapeutics: CRISPR-Enabled Technology Might Unlock New Therapies
03:20pm, Monday, 28'th Dec 2020
Synthetic Lethality (SL) is a promising approach for cancer treatments. Repare's SNIPRx platform has the potential to identify SL pairs to create new therapies.
Repare Therapeutics Added to the NASDAQ Biotechnology Index
04:05pm, Thursday, 17'th Dec 2020
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics, Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprieta
Repare Therapeutics to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
07:00am, Monday, 23'rd Nov 2020
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietar
